Endostar continuous versus intermittent intravenous infusion combined with chemotherapy for advanced NSCLC: a systematic review and meta-analysis including non-randomized studies

Both intermittent intravenous (IIV) infusion and continuous intravenous (CIV) infusion of Endostar are widely used for NSCLC in China. We aimed to compare the efficacy and safety of CIV of Endostar versus IIV ...

Source: BMC Cancer - October 21, 2020 Category: Cancer & Oncology Authors: Bo Wang, Lu Xu, Qihuan Li, Sailimai Man, Cheng Jin, Lian Liu, Siyan Zhan and Yi Ning Tags: Research article Source Type: research